Drug Drug Interaction of Empagliflozin (BI 10773) and Warfarin in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2010

Conditions
Healthy
Interventions
DRUG

BI 10773 25 mg

25 mg BI 10773 qd for 5 days

DRUG

Warfarin 25 mg

25 mg Warfarin single dose

DRUG

BI 10773 25 mg

25 mg BI 10773 qd for 12 days

DRUG

Warfarin

25 mg warfarin single dose with and without 50 mg BI 10773

Trial Locations (1)

Unknown

1245.18.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY